:: Library Catalog

Cover Image

Saved in:

Bibliographic Details
Main Authors:	Zhonghan Zhang, Jinhui Xue, Yunpeng Yang, Wenfeng Fang, Yan Huang, Shen Zhao, Fan Luo, Jiaxin Cao, Kangmei Zeng, Wenjuan Ma, Jianhua Zhan, Feiteng Lu, Li Zhang, Hongyun Zhao
Format:	Artículo Open Access
Published:	Wiley 2024
Subjects:	MedComm
Online Access:	https://onlinelibrary.wiley.com/doi/10.1002/mco2.586
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Phase 1b trial of anti‐HER2 antibody inetetamab and pan‐HER inhibitor pyrotinib in HER2‐positive advanced lung cancer
by: Yihua Huang, et al.
Published: (2024)

First‐Line Third‐Generation EGFR Tyrosine Kinase Inhibitor Monotherapy for Advanced EGFR‐Mutated Non‐Small Cell Lung Cancer: A Systematic Review and Network Meta‐Analysis
by: Wei Du, et al.
Published: (2025)

Mechanisms of resistance to tyrosine kinase inhibitor‐targeted therapy and overcoming strategies
by: Xuejin Ou, et al.
Published: (2024)

Phase I Clinical Trial of CVL218, a Novel PARP1/2 Inhibitor, in Patients with Advanced Solid Tumors
by: Zihong Chen, et al.
Published: (2025)

Dual Targeting of DNA and EGFR by ZYH005 Induces DNA Damage and Mitotic Catastrophe in Glioblastoma
by: Jianzheng Huang, et al.
Published: (2026)

Genome‐scale CRISPR–Cas9 screen identifies PAICS as a therapeutic target for EGFR wild‐type non‐small cell lung cancer
by: Yufeng Li, et al.
Published: (2024)

Transmembrane protein 25 abrogates monomeric EGFR‐driven STAT3 activation in triple‐negative breast cancer
by: Chakrabhavi Dhananjaya Mohan, et al.
Published: (2024)

Sphingosine‐1‐Phosphate Receptor 3 Confers Tumor Metastasis in Lung Cancer Resistant to Third‐Generation EGFR Inhibitor
by: Mengzhen Lai, et al.
Published: (2026)

The combination of tumor mutational burden and T‐cell receptor repertoire predicts the response to immunotherapy in patients with advanced non–small cell lung cancer
by: Yalun Li, et al.
Published: (2024)

VEGF Signal Complexity Confers Resistance to Atezolizumab, Bevacizumab, Carboplatin, and Paclitaxel in EGFR‐Tyrosine Kinase Inhibitor‐Resistant Non‐Small Cell Lung Cancer
by: Sehwa Hong, et al.
Published: (2025)

Addition of anti‐PD‐1 immunotherapy to BRAF inhibitor‐based targeted therapy improves real‐world survival and delays brain metastases in patients with BRAFV600‐mutant advanced melanoma: a multicenter cohort study
by: Junwan Wu, et al.
Published: (2025)

Next‐generation sequencing identifies that protein tyrosine phosphatase receptor type D mutation is favorable to immunotherapy in human cancer
by: Yongsheng Huang, et al.
Published: (2024)

Tyrosine kinase inhibitors in HER2‐positive metastatic breast cancer with trastuzumab emtansine resistance: insights from a multicenter retrospective real‐world study
by: Chunxiao Sun, et al.
Published: (2024)

Comprehensive multi‐omics analysis provides biological insights and therapeutic strategies for small‐cell lung cancer
by: Guo Zhao, et al.
Published: (2024)

Remodeling tumor‐associated macrophage for anti‐cancer effects by rational design of irreversible inhibition of mitogen‐activated protein kinase‐activated protein kinase 2
by: Danyi Wang, et al.
Published: (2024)

Targeting RAC1 reactivates pyroptosis to reverse paclitaxel resistance in ovarian cancer by suppressing P21‐activated kinase 4
by: Jiangchun Wu, et al.
Published: (2024)

Phase I clinical trial to assess safety and efficacy of Oraxol, a novel oral paclitaxel chemotherapy agent, in patients with previously treated metastatic breast cancer
by: Yunfang Yu, et al.
Published: (2025)

Induction immunochemotherapy followed by definitive chemoradiotherapy for unresectable locally advanced non‐small cell lung cancer: a multi‐institutional retrospective cohort study
by: Leilei Wu, et al.
Published: (2024)

Fusobacterium nucleatum Promotes the Growth and Metastasis of Colorectal Cancer by Activating E‐Cadherin/Krüppel‐Like Factor 4/Integrin α5 Signaling in a Calcium‐Dependent Manner
by: Xuebing Yan, et al.
Published: (2025)

Mechanism of Musashi2 affecting radiosensitivity of lung cancer by modulating DNA damage repair
by: Hongjin Qu, et al.
Published: (2024)

Associations of blood pressure in the third trimester and risk of venous thromboembolism postpartum
by: Qian Li, et al.
Published: (2024)

Dedicator of cytokinesis 8 (DOCK8) mutation impairs the differentiation of helper T cells by regulating the glycolytic pathway of CD4+ T cells
by: Panpan Jiang, et al.
Published: (2024)

Osteoarthritis synovium as a nidus for monosodium urate crystal deposition inducing severe gout studied by label‐free stimulated Raman scattering combined with synovial organoids
by: Ziyi Chen, et al.
Published: (2025)

Rheumatoid arthritis: pathogenesis and therapeutic advances
by: Ying Gao, et al.
Published: (2024)

Case series: Brolucizumab efficacy and safety in treating neovascular age‐related macular degeneration
by: Linling Cheng, et al.
Published: (2025)

Changes in L‐phenylalanine concentration reflect and predict response to anti‐PD‐1 treatment combined with chemotherapy in patients with non‐small cell lung cancer
by: Yaqing Liu, et al.
Published: (2025)

Tofacitinib for elderly onset hemophagocytic lymphohistiocytosis with gene mutations: a case report
by: Tingting Liu, et al.
Published: (2024)

Antiangiogenic Medications Impede the Oral Mucosal Microcirculation and Interfere with Oral Wound Healing: A Complication Deserving of Attention
by: Hongyuan Huang, et al.
Published: (2025)

Renal cancer: signaling pathways and advances in targeted therapies
by: Aimin Jiang, et al.
Published: (2024)

Gut microbiota in health and disease: advances and future prospects
by: Yusheng Zhang, et al.
Published: (2024)

Development of potent pan‐coronavirus fusion inhibitors with a new design strategy
by: Yuanmei Zhu, et al.
Published: (2024)

Insight into Janus kinases specificity: From molecular architecture to cancer therapeutics
by: Tian‐Hua Wei, et al.
Published: (2024)

Differential expression of the MYC‐Notch axis drives divergent responses to the front‐line therapy in central and peripheral extensive‐stage small‐cell lung cancer
by: Libo Luo, et al.
Published: (2025)

Novel vaccine strategies to induce respiratory mucosal immunity: advances and implications
by: Ming Zhou, et al.
Published: (2025)

Adenoid cystic carcinoma: insights from molecular characterization and therapeutic advances
by: Yunxuan Jia, et al.
Published: (2024)

Cardiomyogenic differentiation of an induced pluripotent stem cell line carrying PRKAG2 R302Q mutation
by: Yi Gu, et al.
Published: (2024)

Perioperative immunotherapy: the main clinical treatment for resectable non‐small cell lung cancer
by: Zhijun Yuan, et al.
Published: (2024)

Targeting EZH1/2: tackling epigenetic resistance advances cancer therapy
by: Ram Abou Zaki, et al.
Published: (2025)

DLGAP5 mutations Disrupt Normal Chromosome Segregation and Spindle Formation of human Oocyte Meiosis and Lead to Female Infertility
by: Meng Wang, et al.
Published: (2025)

A recent advancement in the delivery of CAR‐T: Use lyophilized lymph nodes
by: Xinze Du, et al.
Published: (2024)